Aptinyx Stock Price. Everything You Need To Know About The Aptinyx Stock!
Aptinyx Inc. is an Evanston, Illinois-based clinical stage biopharmaceutical company that focuses on discovering, developing, and commercializing transformative therapies for disorders of the brain and nervous system. With a strong emphasis on targeting and modulating N-methyl-D-aspartate receptors (NMDArs), Aptinyx has three product candidates in clinical development for central nervous system indications: chronic pain, post-traumatic stress disorder, and cognitive impairment.
One of Aptinyx’s lead product candidates, NYX-2925, is currently in Phase II clinical development for the treatment of chronic pain. It enables synaptic plasticity in the brain, a mechanism that is unique from any therapy currently used for the treatment of chronic pain. Additionally, Aptinyx’s product pipeline includes NYX-783, which is in Phase II clinical development for the treatment of post-traumatic stress disorder, and NYX-458, currently in Phase II clinical development for the treatment of cognitive impairment.
Since the company went public in June 2018, Aptinyx has steadily grown, currently employing 12 full-time employees. While we cannot provide specific information about the company’s stock price or market cap, it is vital for investors to research Aptinyx’s stock to stay up-to-date with the industry. With a focus on transformative therapies for disorders of the brain and nervous system, Aptinyx is a company that investors should keep an eye on as it continues to grow and develop its innovative products.
Aptinyx Stock Price. Everything You Need To Know About The Aptinyx Stock! performance
- Employees 12
- Company HQ Evanston
- Website https://www.aptinyx.com/
- Asset Type
- Market Capitalization 0
- Earnings Per Share
- Dividends Per Share
- Dividend Date
- Quarterly Earnings Growth
Are you a retail investor in Malaysia, Thailand, Indonesia or Vietnam looking to invest in promising US stocks? Look no further than Aptinyx! Aptinyx is a pharmaceutical company focused on discovering and developing transformative therapies for neurological and psychiatric disorders. With a strong pipeline of innovative treatments, this stock presents an exciting investment opportunity. But how can you invest in Aptinyx from Malaysia, Thailand, Indonesia, or Vietnam? Zorion, the leading investment platform, is here to guide you on this journey. Zorion offers investment insights and recommendations to help you make informed decisions about your investments. Our team of experts curates educational resources and industry-leading research to further enhance your investment knowledge. With Zorion, investing in Aptinyx and other US stocks has never been easier. Take advantage of our user-friendly interface and access our comprehensive investment tools. Start your investment journey today with Zorion and be a part of the exciting future of Aptinyx!
